Status:
UNKNOWN
Asphyxia Associated Metabolite Biomarker Investigation 2
Lead Sponsor:
InfanDx AG
Collaborating Sponsors:
Cukurova University
University Children's Hospital Tuebingen
Conditions:
Birth Asphyxia
Eligibility:
All Genders
22-48 years
Brief Summary
Follow-up of participants of AAMBI1 study at age of at least 2 years. AAMBI1(ClinicalTrials.gov ID: NCT03354208): Verification of biomarkers in a human population for their ability to diagnose the sev...
Detailed Description
Follow-Up on neuro-developmental status of Study participants of AAMBI1. AAMBI1(ClinicalTrials.gov ID: NCT03354208): The aim of the study is to verify the application of combinations of several labora...
Eligibility Criteria
Inclusion
- Infants previously enrolled in the AAMBI1 study
Exclusion
- Missing valid written informed parental consent
Key Trial Info
Start Date :
July 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT04714502
Start Date
July 2 2019
End Date
December 31 2021
Last Update
January 19 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Turkey Cukurova University
Adana, Turkey (Türkiye), 01330
2
University of Firat
Elâzığ, Turkey (Türkiye), 23110
3
Özel Güngören Hastanesi
Istanbul, Turkey (Türkiye), 34164
4
Mersin University School of Medicine
Mersin, Turkey (Türkiye), 33343